Several laws support the approval of drugs for pediatric use:
Best Pharmaceuticals for Children Act (BPCA): Provides incentives for pharmaceutical companies to conduct pediatric studies. Pediatric Research Equity Act (PREA): Requires drug companies to study their products in children if they are likely to be used in this population. Orphan Drug Act: Encourages the development of drugs for rare pediatric diseases through various incentives.
